“Systems biology” is in the process of taking off in Trondheim and at international level, and what is special this time is that Norwegian scientists are not belatedly linking up with European research, but hold a key position right from the start.
An imposing infrastructure has been built up in the course of the past ten years inside the buildings occupied by SINTEF Materials and Chemistry. Stimulated by the demanding requirements of Norwegian industry, NOK 6 – 8 million has been invested in robots and a total of NOK 18 million in laboratory equipment. Today, the equipment and laboratories are unique on both Norwegian and European levels.
Upgrading over the years
Micro-organisms are used, among other things, to produce medicines and chemicals worth millions of kroner, as well as to support the development of a strong industrial cluster. SINTEF’s Department of Biotechnology has almost thirty years of experience of using bacteria in production processes.
Around 1990 there were four 10-litre bioreactors or fermenters in this department - in addition to a pilot plant with two large 300-litre and 1500-litre tanks. In the mid-90s, 32 new three-litre fermenters were added. “These were soon in full production”, says research scientist Håvard Sletta. “In fact, every year we run somewhere between 500 and 1000 fermentations with our equipment”.
As well as upgrading the fermentation side, the group has also built up a screening laboratory in which bacteria are cultivated on microlitre scale in order to test tens of thousands of strains of bacteria a year. While scientists once used toothpicks to manually pick out hundreds of bacterial cultures, work of this sort is done nowadays by robots, which can pick as many as 10,000 colonies a day and transfer them to the appropriate trays for recultivation and analysis.
“Selecting and cultivating good strains of bacteria plays an important role in our work”, says Sletta. We acquired our first robot in 2000, and we currently have three of them in the screening laboratory; picking out colonies, pipetting and diluting thousands of small sample cultures.
The analytical laboratory too is as good as complete, being equipped with mass spectrometers to analyse the bacterial samples. Everything is done efficiently and is quality-assured with the aid of the modern equipment. A new NOK 5 million investment programme is just round the corner.
Genetics and modelling
For the past few years, the group has been working on genetics, as a result of its desire for better control of the processes involved. In this area, the competence of the NTNU side is making a strong contribution.
At this point in time, the group is taking the next step, and starting research on systems biology, where the scientists’ aim is to develop mathematical models of living organisms. Among the strengths of the Norwegian group are cultivation and analysis, which have brought it into projects financed via ERA-Net, a cooperative venture that involves research councils in several countries.
“This is interesting for us”, says Sletta. “By drawing on the competence of our European partners, we can develop models that tell us how we need to change the bacteria or their conditions of cultivation in order to improve production. Our aim is that our models should be capable of predicting optimal conditions, thus enabling us to cut down on the number of test trials.
“Now we are beginning to harvest the fruits of upgrading our equipment. We are currently running a number of large projects in the laboratory today, we are generating new projects, and now we are also a member of European projects. With the new network, we can do things that we would not have able to manage otherwise”, says Håvard Sletta
Aase Dragland | alfa
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences